Radiation-induced nausea and vomiting

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 5, Issue 1, 2007, Pages 60-65

  Urba, Susan ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Anti emetics; Emesis; Nausea; Radiation

Indexed keywords

APREPITANT; DEXAMETHASONE; DOLASETRON MESILATE; GRANISETRON; ONDANSETRON; PALONOSETRON;

ABDOMINAL RADIOTHERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSE RESPONSE; HUMAN; NAUSEA AND VOMITING; PRACTICE GUIDELINE; RADIATION DOSE; RADIATION FIELD; REVIEW;

EID: 33846842486     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2007.0008     Document Type: Review

References (14)

1. Danjoux CE, Rider WD, Fitzpatrick PJ. The acute radiation syndrome. A memorial to William Michael Court-Brown. Clin Radiol 1979;30:581-584.
2. The Italian Group for Antiemetic Research in Radiotherapy. Radiation-induced emesis: a prospective observational multicenter Italian trial. Int J Radiat Oncol Bio Phys 1999;44:619-625.
3. Horiot JC. Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting? Int J Radiat Oncol Biol Phys 2004;15:1018-1025.
4. Ettinger DS, Bierman PJ, Bradbury B, et al. The NCCN antiemesis clinical practice guidelines in oncology, version 2, 2006. Available at: http://www.nccn.org/physician_gls/index.html. Accessed November 2, 2006.
5. Multinational Association of Supportive Care in Cancer. Antiemetic Guideline Consensus. Available at: http://www.mascc.org/ktml2/images/uploads/ Resource_centers/MASCC_Guidelines_Update_9_05.pdf. Accessed November 2, 2006.
6. American Society of Clinical Oncology, Kris MG, Hesketh PJ, et al. American Society of Clinical Oncology guidelines for antiemetics in oncology: update 2006. J Clin Oncol 2006;24:2932-2947.
7. Belkacemi Y, Ozsahin M, Pene F, et al. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis. Int J Radiat Oncol Biol Phys 1996;36:77-82.
8. Spitzer TR, Friedman CJ, Bushnell W, et al. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation. Bone Marrow Transplant 2000;26:203-210.
9. Gralla R, Lichinitser M, Van Der Vegt S, et al. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol 2003;14:1570-1577.
10. Eisenberg P, Figueroa-Vadillo J, Zamora R, et al. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron. Cancer 2003;98:2473-2482.
11. Aapro M, Grunberg S, Manikhas G, et al. A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 2006;17:1441-1449.
12. Franzen L, Nyman J, Hagberg H, et al. A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy. Ann Oncol 1996;7:587-592.
13. Kirkbride P, Bezjak A, Pater J, et al. Dexamethasone for the prophylaxis of radiation induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study. J Clin Oncol 2000;18:1960-1966.
14. Lanciano R, Sherman DM, Michalski J, et al. The efficacy and safety of once-daily kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy. Cancer Invest 2001;19:763-772.